JOHNSON & JOHNSON COVID-19 VACCINE GETS APPROVED IN US

  • 28/02/2021

The United States of America (USA)  approved Johnson and Johnson's single-dose COVID-19 vaccine  for emergency use authorisation. Johnson and Johnson is the third authorised COVID-19 vaccine in the US.The US Food and Drug Administration has said that the Janssen COVID-19 vaccine is "safe and effective" in preventing the infection. It also said that the available data shows that the vaccine's known and potential benefits outweigh its known and potential risks, supporting the company's request for the vaccine's use in people of 18 years of age and older.

The Johnson and Johnson COVID-19 vaccine is a single-dose vaccine that does not require special storage. On the other, Pfizer Moderna vaccines, which are based on new messenger RNA technology, are two-dose vaccines and require special storage.

Related News